Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Biological, Procedure, Drug
  • Participants: 60
  • Start Date: October 22, 2020
Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 126
  • Start Date: April 2020
Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Elderly Patients With Newly Diagnosed Multiple Myeloma
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation, Drug
  • Participants: 20
  • Start Date: November 19, 2019
A Pilot Study Evaluating Lenalidomide and CC-486 in Combination With Radiotherapy For Patients With Plasmacytoma (LENAZART Study)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 180
  • Start Date: October 2, 2019
Influenza Vaccination in Plasma Cell Dyscrasias
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Procedure, Drug
  • Participants: 50
  • Start Date: January 5, 2018
Phase II Open Lable Clinical Study Efficacy and Safety of the Holistic Treatment for Young Patients With High-Risk Multiple Myeloma
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation
  • Participants: 50
  • Start Date: October 1, 2017
Phase I/II Trial of Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Other
  • Participants: 140
  • Start Date: March 10, 2017
Phase III Randomised Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Other
  • Participants: 34
  • Start Date: October 31, 2016
Ixazomib, Lenalidomide, and Dexamethasone for Patients With POEMS Syndrome
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Other
  • Participants: 17
  • Start Date: December 24, 2015
Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia
Showing 1-12 of 17